Azacitidin Ideogen 100 mg, Pulver zur Herstellung einer Injektionssuspension

7680679660014 CH-67966 Pulver zur Herstellung einer Injektionssuspension
Azacitidin Ideogen 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Ideogen 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Ideogen 100 mg, Pulver zur Herstellung einer Injektionssuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver zur Herstellung einer Injektionssuspension
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/11/2024
Summary of Product Characteristics
Français
13/11/2024
Summary of Product Characteristics
Italien
13/11/2024

Detailed composition

Substance Quantity Type Category
PRC
100.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 223.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2022

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
67966
Drug name
Azacitidin Ideogen, Pulver zur Herstellung einer Injektionssuspension
Galenic form
PULVS
ATC Code
L01BC07
Authorization status
Z
Dispensing category
A
First authorization
07/06/2021
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
AZACITIDIN Ideogen subst sèche 100 mg flac
Description (DE)
AZACITIDIN Ideogen Trockensub 100 mg Durchstf
Market launch
07/06/2021
Narcotic (BTM)
No

Original drug

Vidaza, Lyophilisat zur Herstellung einer Injektionssuspension
GTIN: 7680573800011
CHF 350.75
View original